<DOC>
	<DOCNO>NCT02257632</DOCNO>
	<brief_summary>The purpose study compare effect intravitreal injection ranibizumab aflibercept systemic VEGF protein level treatment na√Øve wAMD patient detailed time course .</brief_summary>
	<brief_title>Systemic VEGF Protein Dynamics Following Intravitreal Injections Ranibizumab Versus Aflibercept Patients With Neovascular Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Visual impairment predominantly due neovascular AMD . Active , newly diagnose , untreated , angiographically document , CNV lesion ( i.e . leakage fluorescein angiography plus intraretinal , subretinal subRPE fluid OCT ) secondary neovascular AMD line SmPC ranibizumab aflibercept Stroke myocardial infarction le 3 month prior screen . Presence uncontrolled systolic blood pressure diastolic blood pressure Type 1 Type 2 diabetes mellitus Use systemic antiVEGF drug Use systemic inhale corticosteroid least 30 consecutive day within 3 month prior screen . Women pregnant breast feed menstruate capable become pregnant* practice medically approve method contraception For either eye : Any active periocular ocular infection inflammation Uncontrolled glaucoma Neovascularization iris neovascular glaucoma History treatment antiangiogenic drug For study eye : Atrophy fibrosis involve center fovea time screen baseline . Cataract ( cause significant visual impairment ) , plan cataract surgery study period , vitrectomy , aphakia , glaucoma surgery , severe vitreous hemorrhage , rhegmatogenous retinal detachment , proliferative retinopathy choroidal neovascularization cause wAMD Irreversible structural damage within 0.5 disc diameter center macula Any intraocular procedure ( include cataract surgery , YttriumAluminumGarnet capsulotomy ) within 3 month prior baseline anticipate within next 6 month follow baseline . Use intravitreal topical ocular corticosteroid administer least 30 consecutive day within 3 month prior screen . For fellow eye Retinal choroidal neovascularization macula edema cause Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>